OmniAb (OABI) Debt Ratio (2021 - 2026)

OmniAb's (OABI) quarterly Debt Ratio came in at 0.0 in Q1 2026, up 195.97% year-on-year from 0.0 in Q1 2025, and down 1.65% on a QoQ basis from 0.0 in Q4 2025.

OmniAb (OABI) Debt Ratio (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.

  • On a quarterly basis, Debt Ratio rose 195.97% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 195.97% increase from a year earlier, with the FY2025 full-year figure at 0.0, up 112.71% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.0, down from 0.0 in the prior quarter.
  • Over the last five years, Debt Ratio for OABI reached as high as 0.01 in Q4 2022 and fell as low as 0.0 in Q1 2022.
  • Historically, Debt Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2024.
  • Across the five-year window, Debt Ratio surged 3224.45% in 2023 and plunged 85.97% in 2024, its largest moves.
  • Year by year, Debt Ratio stood at 0.01 in 2022, then plunged by 63.63% to 0.0 in 2023, then sank by 53.03% to 0.0 in 2024, then surged by 112.71% to 0.0 in 2025, then slipped by 1.65% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Jun 30, 2021 0.00